FSHR and ovarian cancer: Furthermore, the exclusive expression of the FSH receptor in the reproduction system, particularly in ovarian tissue to mature follicles under the influence of FSH, along with its reported maintenance in ovarian cancers while being absent in other healthy tissue, underscores its attractive appearance as a therapeutic target [10,11,12,13,14].